株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インドにおける医薬品研究開発および製造受託サービス(CRAMS)市場

Contract Research and Manufacturing (CRAMS) Service Market in India 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 310803
出版日 ページ情報 英文 48 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
インドにおける医薬品研究開発および製造受託サービス(CRAMS)市場 Contract Research and Manufacturing (CRAMS) Service Market in India 2014-2018
出版日: 2014年08月20日 ページ情報: 英文 48 Pages
概要

医薬品研究開発および製造受託サービス(CRAMS)とは、研究開発サービス/製造活動を低価格で提供できる組織へアウトソーシングするプロセスとして定義されます。CRAMSは基本的に研究開発受託と製造受託の2つの活動で構成されています。CRAMSは主に広範囲のR&Dおよび大規模な製造施設を必要とする医薬品・バイオテクノロジー部門で利用されます。インドにおけるCRAMS市場は2013-2018年の期間中、32.67%のCAGRで成長すると予測されています。

当レポートでは、インドにおける医薬品研究開発および製造受託サービス(CRAMS)市場について分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 略語集

第3章 調査範囲

  • 市場概要
  • 提供製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模・予測

第7章 インドにおけるCRAMS市場のメリット分析

  • ファイブフォース分析

第8章 市場区分:分類別

  • インドにおける医薬品研究開発受託市場
  • インドにおける医薬品製造受託市場

第9章 購入基準

第10章 市場成長促進要因

第11章 市場成長促進要因とその影響

第12章 市場課題

第13章 市場成長促進要因・課題

第14章 市場動向

第15章 動向とその影響

第16章 ベンダー情勢

  • 競争状況
  • 市場シェア分析
  • その他の有望ベンダー

第18章 主要ベンダーの分析

  • Biocon Ltd.
    • 事業概要
    • 事業区分
    • 主要情報
    • SWOT分析
  • Dishman Pharmaceuticals and Chemicals Ltd.
  • Divis Laboratories Ltd.
  • Jubilant Life Sciences Ltd.
  • Piramal Healthcare Ltd.

第19章 その他の関連レポート

図表リスト

目次
Product Code: IRTNTR3918

About CRAMS

CRAMS is defined as the process of outsourcing research services/ product manufacturing activities to organizations which can provide the service at a low cost. CRAMS basically consists of the following two activities: contract research and contract manufacturing. CRAMS is mainly used in the Pharmaceutical and Biotechnology sectors that require extensive R&D and large-scale manufacturing facilities. It is expected that the demand for contract research and contract manufacturing is expected to increase in India in the future.

TechNavio's analysts forecast the CRAMS market in India to grow at a CAGR of 32.67 percent over the period 2013-2018.

Covered in this Report

In terms of activities, the CRAMS market in India can be segmented into two: Contract Research and Contract Manufacturing. To calculate the market size, the report considers the revenue generated from the services offered by contract research and contract manufacturing organizations to other equipment manufacturers (OEMs) for the manufacturing of new chemical entities, API, and pre-clinical and clinical research.

TechNavio's report, the CRAMS Market in India 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the CRAMS market in India and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • India

Key Vendors

  • Biocon
  • Dishman Pharmaceuticals and Chemicals
  • Divis Laboratories
  • Jubilant Life Sciences
  • Piramal Healthcare

Other Prominent Vendors

  • Aurbindo Pharma
  • Cadila Healthcare
  • Dr. Reddy's Laboratories
  • GVK Biosciences
  • Ipca Laboratories
  • Lupin
  • Quintiles
  • Siro Clinpharm
  • Sun Pharmaceutical
  • Wockhardt

Market Driver

  • Rising Cost of Research in Developed Markets

For a full, detailed list, view our report

Market Challenge

  • Growing Global Competition

For a full, detailed list, view our report

Market Trend

  • Increase in Strategic Alliances

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast

07. Benefit Analysis of CRAMS Market in India

  • 07.1. Five Forces Analysis

08. Market Segmentation by Category

  • 08.1. Contract Research Market in India
    • 08.1.1. Market Size and Forecast
  • 08.2. Contract Manufacturing Market in India
    • 08.2.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Market Share Analysis 2013
  • 16.3. Other Prominent Vendors

17. Competitive Assessment of Major Players

18. Key Vendor Analysis

  • 18.1. Biocon Ltd.
    • 18.1.1. Business Overview
    • 18.1.2. Business Segmentation
    • 18.1.3. Key Information
    • 18.1.4. SWOT Analysis
  • 18.2. Dishman Pharmaceuticals and Chemicals Ltd.
    • 18.2.1. Business Overview
    • 18.2.2. Business Segmentation
    • 18.2.3. Key Information
    • 18.2.4. SWOT Analysis
  • 18.3. Divis Laboratories Ltd.
    • 18.3.1. Business Overview
    • 18.3.2. Key Information
    • 18.3.3. SWOT Analysis
  • 18.4. Jubilant Life Sciences Ltd.
    • 18.4.1. Business Overview
    • 18.4.2. Business Segmentation
    • 18.4.3. Key Information
    • 18.4.4. SWOT Analysis
  • 18.5. Piramal Healthcare Ltd.
    • 18.5.1. Business Overview
    • 18.5.2. Key Information
    • 18.5.3. SWOT Analysis

19. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: CRAMS Market in India 2013-2018 (US$ billion)
  • Exhibit 3: CRAMS Market in India Segmentation by Category
  • Exhibit 4: CRAMS Market in India by Market Segmentation 2013
  • Exhibit 5: Contract Research Market in India 2013-2018 (US$ billion)
  • Exhibit 6: Contract Manufacturing Market in India 2013-2108 (US$ billion)
  • Exhibit 7: CRAMS Market in India Segmentation by Category 2013-2018 (US$ billion)
  • Exhibit 8: CRAMS Market in India Segmentation by Category 2013-2018 (in percent)
  • Exhibit 9: Business Segmentation of Biocon Ltd.
  • Exhibit 10: Business Segmentation of Dishman Pharmaceuticals and Chemicals Ltd.
  • Exhibit 11: Business Segmentation of Jubiliant Life Sciences Ltd.
Back to Top